Press Releases Prenetics Global Limited

Equities

PRE

KYG722451229

Delayed Nasdaq Other stock markets 10:41:59 14/05/2024 pm IST			5-day change	1st Jan Change
6.191 ^USD	-0.47%		+12.36%	+4.75%

01/04	Prenetics Global Limited Reports Impairment Loss of Goodwill for the Fourth Quarter Ended December 31, 2023	CI
01/04	Prenetics Global Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results	01/04	AQ
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station	09/02	AQ
PRENETICS GLOBAL : REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT - Form 6-K	30/11	PU
Prenetics Announces Third Quarter 2023 Financial Results	20/11	AQ
Prenetics Global Limited Announces Reverse Stock Split	01/11	GL
Prenetics Announces Second Quarter 2023 Financial Results	15/23/15	GL
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV	30/23/30	AQ
Prenetics Global : NASDAQ Notification Regarding Minimum Bid Price Deficiency - Form 6-K	30/23/30	PU
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening	26/23/26	AQ
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening	26/23/26	GL
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening	26/23/26	AQ
Prenetics Global : Investor Presentation (26 June 2023)	26/23/26	PU
Prenetics Announces First Quarter 2023 Financial Results	05/23/05	GL
Prenetics Global : UPDATE - Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results	02/23/02	PU
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology	14/23/14	AQ
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results	14/23/14	GL
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology	04/23/04	AQ
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology	02/23/02	GL
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology	02/23/02	AQ
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	03/23/03	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prenetics Global Limited

Equities

PRE

KYG722451229

Press Releases

Filters